DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▲ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0036341 | Schizophrenia | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0476089 | Endometrial Carcinoma | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0007103 | Malignant neoplasm of endometrium | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0002871 | Anemia | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0162316 | Iron deficiency anemia | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0678222 | Breast Carcinoma | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0028043 | Nicotine Dependence | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0600139 | Prostate carcinoma | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0006826 | Malignant Neoplasms | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0149782 | Squamous cell carcinoma of lung | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0024623 | Malignant neoplasm of stomach | CACNA2D3 | 55799 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | Q8IZS8 |
C0005695 | Bladder Neoplasm | ST6GALNAC1 | 55808 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | Q9NSC7 |
C4721610 | Carcinoma, Ovarian Epithelial | ST6GALNAC1 | 55808 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | Q9NSC7 |
C1306459 | Primary malignant neoplasm | ST6GALNAC1 | 55808 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | Q9NSC7 |
C0007102 | Malignant tumor of colon | ST6GALNAC1 | 55808 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | Q9NSC7 |
C0009324 | Ulcerative Colitis | ST6GALNAC1 | 55808 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | Q9NSC7 |
C0036341 | Schizophrenia | ST6GALNAC1 | 55808 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | Q9NSC7 |
C0007103 | Malignant neoplasm of endometrium | ST6GALNAC1 | 55808 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | Q9NSC7 |
C0699791 | Stomach Carcinoma | ST6GALNAC1 | 55808 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | Q9NSC7 |
C0027051 | Myocardial Infarction | ST6GALNAC1 | 55808 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | Q9NSC7 |
C0279626 | Squamous cell carcinoma of esophagus | ST6GALNAC1 | 55808 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | Q9NSC7 |
C0006826 | Malignant Neoplasms | ST6GALNAC1 | 55808 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | Q9NSC7 |
C0006142 | Malignant neoplasm of breast | ST6GALNAC1 | 55808 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | Q9NSC7 |
C0005684 | Malignant neoplasm of urinary bladder | ST6GALNAC1 | 55808 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | Q9NSC7 |
C0476089 | Endometrial Carcinoma | ST6GALNAC1 | 55808 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | Q9NSC7 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024